Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "Safety & Efficacy of Low-Dose Ipi + Pembro in Checkpoint Inhibitor-Naïve Patients With Melanoma Brain Metastases"
54 views
November 6, 2023
Comments 0
Login to view comments.
Click here to Login
Skin